Omega Therapeutics (OMGA) just unveiled an update.
Kaan Certel, Ph.D., with over two decades of experience in the biopharmaceutical sector, has been appointed as the new Chief Business Officer of the Company. Starting May 28, 2024, he will spearhead the company’s global business development and strategic partnerships.
Find detailed analytics on OMGA stock on TipRanks’ Stock Analysis page.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
